Brown Trout Management »

Apellis Pharmaceuticals shares owned by Brown Trout Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Brown Trout Management from 13F filings

Historical chart of Brown Trout Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Brown Trout Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Brown Trout Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.8M 190k 30.32

More positions owned by Brown Trout Management

Chart Industries (GTLS)
Janus Henderson Group Ord Shs (JHG)
Arcellx Common Stock (ACLX)
Bandwidth Note 0.500% 4/0 (Principal)
Amicus Therapeutics (FOLD)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Cracker Barrel Old Ctry Stor Note 0.625% 6/1 (Principal)
Accuray Inc Del Note 3.750% 6/0 (Principal)
Sabre Glbl Note 7.320% 8/0 (Principal)
Mgp Ingredients Note 1.875%11/1 (Principal)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
The Realreal Note 1.000% 3/0 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Nabors Inds Note 1.750% 6/1 (Principal)

View all positions for Brown Trout Management

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
venBio Select Advisor
Vanguard Group
Deep Track Capital
Rtw Investments
BlackRock
State Street Corporation
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
AQR Capital Management
Geode Capital Management
Jennison Associates

View all funds holding Apellis Pharmaceuticals